Drug intelligence / Profile preview

oligo-fucoidan

Development stage
Unknown
Lead developer
Hi-Q Marine Biotech International
Administration
Oral
01

Overview

Oligo-fucoidan is a low-molecular-weight form of fucoidan, a complex sulfated polysaccharide primarily extracted from brown seaweed such as *Sargassum hemiphyllum*. Unlike high-molecular-weight fucoidan, the oligo form is characterized by enhanced bioavailability and solubility, making it more suitable for therapeutic applications. It exerts multi-targeted anti-tumor effects by inhibiting angiogenesis through the downregulation of vascular endothelial growth factor (VEGF), suppressing tumor cell migration and invasion via the HGF/c-Met pathway, and modulating the transforming growth factor beta (TGF-beta) signaling cascade. Additionally, oligo-fucoidan has been shown to enhance immune surveillance by activating natural killer (NK) cells and promoting a Th1-polarized immune response. It is primarily investigated as an adjuvant therapy in advanced hepatocellular carcinoma (HCC) and other solid tumors to improve clinical outcomes and reduce treatment-related toxicity.

Brand names
Oligo-Fucoidan
Other names
Low-molecular-weight fucoidanLMWFsulfated polysaccharide
02

Targets

VEGFR-1 (Vascular endothelial growth factor receptor 1)TLR (Toll-like receptors)αVβ3 (Integrin αVβ3)CD36 (CD36 antigen)MET (Mesenchymal-epithelial transition factor receptor)ASGPR (Asialoglycoprotein Receptor 1)TGFBR (TGF-beta receptor)

Beyond the preview

Go deeper on oligo-fucoidan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oligo-fucoidan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call